Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biomaterials. 2014 Mar 25;35(18):4863–4877. doi: 10.1016/j.biomaterials.2014.02.054

Table 3.

Percentage decrease in viability assessed by Calcein AM assay of adMSCs and bmMSCs treated with GNOs, GONRs and GONPs at concentration of 300 μg/ml at day 1 and 3 compared to control.


adMSC bmMSC

Day 1 Day 3 Day 1 Day 3
GNOs 98% 38% 19% 21%
GONRs 94% 91% 39% 74%
GONPs 65% 80% 62% 74%